USPTO Trademark Application for BCI Medical Services
Summary
The USPTO has received an intent-to-use trademark application (TM99130340) from SUBSENSE for medical services utilizing non-invasive brain-computer interface (BCI) technology. The application covers services such as neurofeedback, cognitive enhancement, health monitoring, and medical consultation.
What changed
The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application (serial number 99130340) from SUBSENSE. The application seeks to trademark services related to non-invasive brain-computer interface (BCI) technology. These services include neurofeedback, cognitive enhancement, brain health monitoring, remote medical data monitoring for diagnosis and treatment, and medical consultation for treatment plans and cognitive rehabilitation.
This filing indicates a potential future market entry for BCI-based medical services. While this is a trademark application and not a regulatory rule, it signals emerging technologies in the healthcare sector. Compliance officers should be aware of the increasing use of BCI technology in medical applications, which may lead to future regulatory considerations regarding data privacy, patient safety, and medical device classification.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
SUBSENSE
Intent to Use TM99130340 Kind: intenttouse Mar 24, 2026
Abstract
Providing medical services using non-invasive brain-computer interface (BCI) technology, including neurofeedback, cognitive enhancement, and brain health monitoring; Providing therapeutic medical services using non-invasive brain-computer interface (BCI) technology, including neurofeedback, cognitive enhancement, and brain health monitoring; Health monitoring and diagnostic services, namely, remote monitoring of medical data for medical diagnosis and treatment and medical diagnostic services, all involving brain-computer interface (BCI) technology for the detection, diagnosis, and treatment of neurological conditions; Medical consultation services utilizing brain-computer interface (BCI) technology for enhancing treatment plans and cognitive rehabilitation therapies
Filing Date
2025-04-10
Related changes
Get daily alerts for USPTO Trademarks - Medical Services (Class 044)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Medical Services (Class 044) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.